Stadium Capital Management LLC Amarin Corp Plcuk Transaction History

Stadium Capital Management LLC

  • $133 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.85 - $1.43 $1.12 Million - $1.88 Million
1,312,525 Added 227.25%
1,890,097 $1.74 Billion
Q2 2023

Aug 14, 2023
BUY
$1.12 - $1.49 $646,880 - $860,582
577,572 New
577,572 $687 Million
Q1 2023

May 15, 2023
SELL
$1.19 - $2.19 $3.33 Million - $6.13 Million
-2,799,160 Reduced 82.15%
608,040 $912,000
Q4 2022

Feb 14, 2023
BUY
$1.07 - $1.34 $3.65 Million - $4.57 Million
3,407,200 New
3,407,200 $4.12 Million

Others Institutions Holding AMRN

# of Institutions
177
Shares Held
65.1M
Call Options Held
258K
Put Options Held
98K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Stadium Capital Management LLC Portfolio

Follow Stadium Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stadium Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stadium Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email